Cleared Abbreviated

K234041 - Fully Automatic Electronic Blood Pressu...

Also marketed or referenced as:
Fully Automatic Electronic Blood Pressure Monitor (KD-5811BT) Fully Automatic Electronic Blood Pressure Monitor (KD-5810VA) Fully Automatic Electronic Blood Pressure Monitor (KD-5810BT) Fully Automatic Electronic Blood Pressure Monitor (KD-5920VA) Fully Automatic Electronic Blood Pressure Monitor (KD-5920BT) Fully Automatic Electronic Blood Pressure Monitor (KD-5923TS)

K234041 is the FDA 510(k) clearance for Fully Automatic Electronic Blood Pressu... by Andon Health Co, Ltd.. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Abbreviated 510(k) pathway after a 123-day FDA review.

K234041 · Andon Health Co, Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2024
Decision
123d
Days
Class 2
Risk

K234041 is an FDA 510(k) clearance for the Fully Automatic Electronic Blood Pressure Monitor (KD-5811VA). Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Andon Health Co, Ltd. (Tianjin, CN). The FDA issued a Cleared decision on April 22, 2024 after a review of 123 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Andon Health Co, Ltd. devices

Submission Details

510(k) Number K234041 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 21, 2023
Decision Date April 22, 2024
Days to Decision 123 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
2d faster than avg
Panel avg: 125d · This submission: 123d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 500
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K234041.
Blood Pressure Monitor (BBZ32-AA01)
K240832 · Guangdong Transtek Medical Electronics Co., Ltd. · Jun 2024
Blood Pressure Monitor (TMB-2296-BT)
K240254 · Guangdong Transtek Medical Electronics Co., Ltd. · May 2024
Blood Pressure Monitor (TMB-2287-B)
K240102 · Guangdong Transtek Medical Electronics Co., Ltd. · Apr 2024
Clinical Automatic Blood Pressure Monitor (DBP-01P,DBP-01HP)
K231984 · Shenzhen Hingmed Medical Instrument Co., Ltd. · Mar 2024
Blood Pressure Monitor
K233146 · Shenzhen Jamr Technology Co., Ltd. · Mar 2024
Wrist Blood Pressure Monitor (222)
K233799 · Shenzhen Yuezhongxing Technology Co., Ltd. · Mar 2024